"Protecting the hearts of central Illinois for over 50 years. National leaders in heart and vascular medicine."

During the past decade, St. John's Hospital, Prairie Education and Research Cooperative conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. John's Hospital, Prairie Education and Research Cooperative" #1 collaborator was "Baim Institute for Clinical Research" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Daiichi Sankyo, Inc." with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "St. John's Hospital, Prairie Education and Research Cooperative" are "Coronary Artery Disease" (2 trials), "Myocardial Ischemia" (2 trials), "Atherosclerosis" (1 trials), "Carotid Artery Disease" (1 trials) and "Chronic Total Occlusion of Coronary Artery" (1 trials). Many other conditions were trialed in "St. John's Hospital, Prairie Education and Research Cooperative" in a lesser frequency.

Most popular intervention types in "St. John's Hospital, Prairie Education and Research Cooperative" are "Device" (4 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "2.25 mm XIENCE V® Everolimus Eluting Coronary Stent System" (1 trials), "Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device." (1 trials), "Carotid WALLSTENT Monorail Endoprosthesis" (1 trials), "FilterWire EZ™ System™" (1 trials) and "XIENCE V Everolimus Eluting Coronary Stent System (XIENCE V EECSS)" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. John's Hospital, Prairie Education and Research Cooperative" are 4 trials for "All" genders.

Currently, there are NaN active trials in "St. John's Hospital, Prairie Education and Research Cooperative". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in St. John's Hospital, Prairie Education and Research Cooperative, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. John's Hospital, Prairie Education and Research Cooperative, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".